Evidence map›Paper›PMID 39548237›Full record

ArticleScientific reports2024

Biocompatible nanocomposite hydroxyapatite-based granules with increased specific surface area and bioresorbability for bone regenerative medicine applications.

Marta Trzaskowska, Vladyslav Vivcharenko, Aleksandra Benko, Wojciech Franus, Tomasz Goryczka, Adrian Barylski, Krzysztof Palka, Agata Przekora

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marta TrzaskowskaDepartment of Tissue Engineering and Regenerative Medicine, Medical University of Lublin, Chodzki 1, 20-093, Lublin, Poland.
Vladyslav VivcharenkoDepartment of Tissue Engineering and Regenerative Medicine, Medical University of Lublin, Chodzki 1, 20-093, Lublin, Poland.
Aleksandra BenkoFaculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza 30, 30-059, Krakow, Poland.
Wojciech FranusDepartment of Construction Materials Engineering and Geoengineering, Lublin University of Technology, Nadbystrzycka 38 D, 20-618, Lublin, Poland.
Tomasz GoryczkaInstitute of Materials Engineering, University of Silesia in Katowice, 75 Pułku Piechoty 1A, 41-500, Chorzów, Poland.
Adrian BarylskiInstitute of Materials Engineering, University of Silesia in Katowice, 75 Pułku Piechoty 1A, 41-500, Chorzów, Poland.
Krzysztof PalkaDepartment of Materials Engineering, Lublin University of Technology, Nadbystrzycka 36, 20- 618, Lublin, Poland.
Agata PrzekoraDepartment of Tissue Engineering and Regenerative Medicine, Medical University of Lublin, Chodzki 1, 20-093, Lublin, Poland. agata.przekora@umlub.pl.

Funding

Narodowe Centrum Nauki UMO-2021/41/N/NZ7/01633
6 · The paper itself

Abstract

Hydroxyapatite (HA) granules are frequently used in orthopedics and maxillofacial surgeries to fill bone defects and stimulate the regeneration process. Optimal HA granules should have high biocompatibility, high microporosity and/or mesoporosity, and high specific surface area (SSA), which are essential for their bioabsorbability, high bioactivity (ability to form apatite layer on their surfaces) and good osseointegration with the host tissue. Commercially available HA granules that are sintered at high temperatures (≥ 900 °C) are biocompatible but show low porosity and SSA (2-5 m

Indexed as

Biocompatible MaterialsBone RegenerationDurapatiteNanocompositesRegenerative MedicineAnimalsCell LineHumansMaterials TestingMiceOsteoblastsPorositySurface PropertiesBiocompatible MaterialsDurapatiteBioceramicsBiocompatibilityBiomaterialsBiopolymersBone regenerationMicrohardness test

Identifiers

PMID39548237
PMCPMC11568164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.